Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Lipodystrophy associated with treatment of HIV‐1 infection

Lipodystrophy associated with treatment of HIV‐1 infection This review describes a lipodystrophy syndrome often seen in recent years in the treatment of HIV-1-positive patients. The syndrome consists of a redistribution in fat, hyperlipidaemia, and insulin resistance, and potentially undermines an important part of the enormous success that the introduction of potent antiretroviral therapy has gained. We describe the different aspects of the syndrome, its implications, and its potential aetiology. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Adverse Drug Reaction Bulletin Wolters Kluwer Health

Lipodystrophy associated with treatment of HIV‐1 infection

Loading next page...
 
/lp/wolters-kluwer-health/lipodystrophy-associated-with-treatment-of-hiv-hyphen-1-infection-1LBnxRqwwz

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Copyright
© 2003 Lippincott Williams & Wilkins
ISSN
0044-6394
eISSN
2159-7774

Abstract

This review describes a lipodystrophy syndrome often seen in recent years in the treatment of HIV-1-positive patients. The syndrome consists of a redistribution in fat, hyperlipidaemia, and insulin resistance, and potentially undermines an important part of the enormous success that the introduction of potent antiretroviral therapy has gained. We describe the different aspects of the syndrome, its implications, and its potential aetiology.

Journal

Adverse Drug Reaction BulletinWolters Kluwer Health

Published: Feb 1, 2003

There are no references for this article.